Novel superantigens from streptococcal toxic shock syndrome Streptococcus pyogenes isolates

Advances in Experimental Medicine and Biology

Volumn 418, Issue , 1997, Pages 525-529

  Newton, Duane ^a,b   Norrby Teglund, Anna ^a   McGeer, Allison ^c   Low, Donald E ^c   Schlievert, Patrick M ^d   Kotb, Malak ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOCOCCUS ANTIGEN; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

BACTERIAL GENE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PYOGENES; TOXIC SHOCK SYNDROME;

EID: 0030762322     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4899-1825-3_123     Document Type: Conference Paper

References (10)

1. Davies, HD, McGeer, A, Schwanz, B, Green, K, Cann, D, Simor, AE, Low, DE, and Group, and the Ontario Group A Streptococcal Study Group. 1996. Invasive group A streptococcal infections in Ontario, Canada. N. Engl. J. Med., 335:547-554.
2. Kotb, M. 1995. Bacterial exotoxins as superantigens. Clin. Microbiol. Rev., 8:411-426.
3. The Working Group on Severe Streptococcal Infections. 1993. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. JAMA, 269:390-1.
4. Demers, B, Simor, A-E, Vellend, H, Schlievert, PM, Byrne, S, Jamieson, F, Valmsley, S, and Low, DE. 1993. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin. Infect. Dis., 16:792-500.
5. Swift, HF, Wilson, AT, and Lancefield, RC. 1943. Typing group A hemolytic streptococci by M precipitin reactions in capillary pipettes. J.Exp. Med., 78:127-133.
6. Norrby-Teglund, A, Newton, D, Kotb, M, Holm, SE, and Norgren, M. 1994. Superantigenic properties of the group A streptococcal exotoxin, SpeF (MF). Infect. Immun., 62:5227-5233.
7. Norrby-Teglund, A, Kaul, R, Low, DE, McGeer, A, Andersson, JR Andersson, UG, and Kotb, M. 1996. Plasma from patients with severe invasive group A streptococcal infections treated with polyspecific IgG (IVIG) inhibits streptococcal superantigen-induced T cell proliferation and cytokine production. J. Immunol., 156:3057-3064.
8. Kotb, M, Watanbe-Ohnishi, R, Wang, B, Tomai, MA, Le Gros, L. Schlievert. P. El Demellawy. M, and Geller, A. 1993. Analysis of the TCR Vß specificities of bacterial superantigens using PCR. Immunomethods. 2:33-40.
9. Baccala, R, Kono, DH, Walker, S, Balderas, RS. and Theofilopoulos, AN. 1991. Genomically imposed and somatically modified human thymocyte V beta gene repertoires. Proc. Natl. Acad. Sci. USA, 88:2908-12.
10. Baccala, R. Gonzalez-Quintial, R, Kono, DH, and Theofilopoulos, AN. 1996. Multiprobe RNase protection assay and sequence enrichement nuclease assay for TCR analysis. (In press).